|
|
|
|
pmid:15226028
|
|
|
|
|
pmid:15236794
|
|
|
|
|
pmid:15238773
|
Ames BN |
Delaying the mitochondrial decay of aging. |
2004 |
Ann. N. Y. Acad. Sci. |
pmid:15247055
|
|
|
|
|
pmid:15247059
|
|
|
|
|
pmid:15283472
|
|
|
|
|
pmid:1529006
|
Cavallini G et al. |
Cinnoxicam and L-carnitine/acetyl-L-carnitine treatment for idiopathic and varicocele-associated oligoasthenospermia. |
2004 Sep-Oct |
J. Androl. |
pmid:15292108
|
|
|
|
|
pmid:15350642
|
Bastianetto S and Quirion R |
Natural antioxidants and neurodegenerative diseases. |
2004 |
Front. Biosci. |
pmid:15353369
|
|
|
|
|
pmid:15383157
|
Roepstorff C et al. |
Malonyl-CoA and carnitine in regulation of fat oxidation in human skeletal muscle during exercise. |
2005 |
Am. J. Physiol. Endocrinol. Metab. |
pmid:15383373
|
|
|
|
|
pmid:1543717
|
Roberts PA et al. |
Acetyl-CoA provision and the acetyl group deficit at the onset of contraction in ischemic canine skeletal muscle. |
2005 |
Am. J. Physiol. Endocrinol. Metab. |
pmid:15454400
|
Evans AM et al. |
Impact of hemodialysis on endogenous plasma and muscle carnitine levels in patients with end-stage renal disease. |
2004 |
Kidney Int. |
pmid:15458447
|
Peluso G et al. |
Differential carnitine/acylcarnitine translocase expression defines distinct metabolic signatures in skeletal muscle cells. |
2005 |
J. Cell. Physiol. |
pmid:15515015
|
|
|
|
|
pmid:15542726
|
|
|
|
|
pmid:15548429
|
Szutowicz A et al. |
Nerve growth factor and acetyl-L-carnitine evoked shifts in acetyl-CoA and cholinergic SN56 cell vulnerability to neurotoxic inputs. |
2005 Jan 1-15 |
J. Neurosci. Res. |
pmid:15558747
|
|
|
|
|
pmid:15591001
|